417 related articles for article (PubMed ID: 18422653)
21. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
22. Damped oscillatory hysteretic behaviour of butyrylcholinesterase with benzoylcholine as substrate.
Masson P; Goldstein BN; Debouzy JC; Froment MT; Lockridge O; Schopfer LM
Eur J Biochem; 2004 Jan; 271(1):220-34. PubMed ID: 14686935
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of pressure and temperature on the catalytic behaviour of wild-type human butyrylcholinesterase and its D70G mutant.
Weingand-Ziadé A; Renault F; Masson P
Eur J Biochem; 1999 Sep; 264(2):327-35. PubMed ID: 10491076
[TBL] [Abstract][Full Text] [Related]
24. Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.
Golicnik M; Sinko G; Simeon-Rudolf V; Grubic Z; Stojan J
Arch Biochem Biophys; 2002 Feb; 398(1):23-31. PubMed ID: 11811945
[TBL] [Abstract][Full Text] [Related]
25. Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
Masson P; Lushchekina S; Schopfer LM; Lockridge O
Biochem J; 2013 Sep; 454(3):387-99. PubMed ID: 23782236
[TBL] [Abstract][Full Text] [Related]
26. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
[TBL] [Abstract][Full Text] [Related]
27. Hydrolysis of oxo- and thio-esters by human butyrylcholinesterase.
Masson P; Froment MT; Gillon E; Nachon F; Lockridge O; Schopfer LM
Biochim Biophys Acta; 2007 Jan; 1774(1):16-34. PubMed ID: 17182295
[TBL] [Abstract][Full Text] [Related]
28. Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover.
Feaster SR; Lee K; Baker N; Hui DY; Quinn DM
Biochemistry; 1996 Dec; 35(51):16723-34. PubMed ID: 8988009
[TBL] [Abstract][Full Text] [Related]
29. Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.
Loewenstein-Lichtenstein Y; Glick D; Gluzman N; Sternfeld M; Zakut H; Soreq H
Mol Pharmacol; 1996 Dec; 50(6):1423-31. PubMed ID: 8967962
[TBL] [Abstract][Full Text] [Related]
30. Inhibition Effects in the Hydrolysis Reactions of Esters and Peptides Catalyzed by Carboxypeptidase A: An Example of Cooperative Binding Effects with a Monomeric Enzyme.
Rahmo A; Fife TH
Bioorg Chem; 2000 Aug; 28(4):226-241. PubMed ID: 11034784
[TBL] [Abstract][Full Text] [Related]
31. Activation mechanisms of butyrylcholinesterase by 2,4,6-trinitrotoluene, 3,3-dimethylbutyl-N-n-butylcarbamate, and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin G
Appl Biochem Biotechnol; 2008 Sep; 150(3):337-44. PubMed ID: 18563305
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of stereoselective interaction between butyrylcholinesterase and ethopropazine enantiomers.
Sinko G; Kovarik Z; Reiner E; Simeon-Rudolf V; Stojan J
Biochimie; 2011 Oct; 93(10):1797-807. PubMed ID: 21740955
[TBL] [Abstract][Full Text] [Related]
33. Substrate dependence of amiloride- and soman-induced conformation changes of butyrylcholinesterase as evidenced by high-pressure perturbation.
Cléry C; Heiber-Langer I; Channac L; David L; Balny C; Masson P
Biochim Biophys Acta; 1995 Jul; 1250(1):19-28. PubMed ID: 7612649
[TBL] [Abstract][Full Text] [Related]
34. Resolution of chiral phosphate, phosphonate, and phosphinate esters by an enantioselective enzyme library.
Nowlan C; Li Y; Hermann JC; Evans T; Carpenter J; Ghanem E; Shoichet BK; Raushel FM
J Am Chem Soc; 2006 Dec; 128(49):15892-902. PubMed ID: 17147402
[TBL] [Abstract][Full Text] [Related]
35. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
36. Nonessential activation and competitive inhibition of bacterial phosphatidylinositol-specific phospholipase C by short-chain phospholipids and analogues.
Zhou C; Roberts MF
Biochemistry; 1998 Nov; 37(46):16430-9. PubMed ID: 9819236
[TBL] [Abstract][Full Text] [Related]
37. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase.
Biberoglu K; Tacal Ö; Akbulut H
Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486
[TBL] [Abstract][Full Text] [Related]
38. Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates.
Schallreuter KU; Gibbons NC; Elwary SM; Parkin SM; Wood JM
Biochem Biophys Res Commun; 2007 Apr; 355(4):1069-74. PubMed ID: 17335779
[TBL] [Abstract][Full Text] [Related]
39. Understanding the molecular mechanism of aryl acylamidase activity of acetylcholinesterase - An in silico study.
Chinnadurai RK; Saravanaraman P; Boopathy R
Arch Biochem Biophys; 2015 Aug; 580():1-13. PubMed ID: 26072115
[TBL] [Abstract][Full Text] [Related]
40. Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid.
Jayanthi LD; Balasubramanian N; Balasubramanian AS
Clin Chim Acta; 1992 Feb; 205(3):157-66. PubMed ID: 1349516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
